Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: GlaxoSmithKline, EMBL-EBI; Geneva Bioinformatics; Ion Torrent Systems; Bruker; Dotmatics, Almirall

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GlaxoSmithKline has teamed with the European Bioinformatics Institute (EMBL-EBI), the US National Library of Medicine, and informatics provider Collaborative Drug Discovery to freely share the chemical structures of 13,500 molecules from GSK's compound library for malaria research. EMBL-EBI will serve as the primary repository for the data on the compound set.


Geneva Bioinformatics (GeneBio) and the Centre Universitaire Romand de Médecine Légale – Unité de Toxicologie et Chimie Forensiques will collaborate on enhancing the capabilities of GeneBio's SmileMS platform for large-scale toxicology studies on AB Sciex Quadrupole Linear Ion Trap Systems. The enhancements will come from a study evaluating the ability of the SmileMS platform to identify illicit substances in saliva samples.


Ion Torrent Systems has awarded one its PGM sequencers to Mitchell Sogin of the Marine Biological Laboratory in Massachusetts as part of the Gordon Moore Environmental Grant. Sogin is director of MBL's Bay Paul Center for Comparative Molecular Biology and Evolution and will use the sequencer to develop technology for water-quality monitoring.


Bruker this week said that the Austrian Agency for Health and Food Safety has selected the firm's MALSI Biotyper for MALDI-TOF analysis of micro-organisms.


Dotmatics said this week that Spanish drug firm Almirall has selected its drug discovery informatics products Vortex and Browser for use in its drug discovery programs.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.